FINDING A MESOTHELIOMA SPECIALISTThe following physicians are specialists in the treatment of malignant mesothelioma.   You will find links to their web sites, when available and to some of   their published articles.They are listed in no particular order with no   particular endorsement.Mesothelioma   is typically treated by an interdisciplinary team of doctors rather   than by a single physician. You may run into professionals called   oncologists, thoracic surgeons, and pulmonologists. Glossary of members of a thoracic oncology care team. More onchoosing your mesothelioma doctor.W. ROY SMYTHE, MDProfessor   and Chairman/Department of Surgery, Texas A&M University System   Health Sciences Center, Scott & White Hospital, Temple, TX
Phone: 254-724-2595Dr.   Smythe is currently accruing patients for a protocol involving   extrapleural pneumonectomy and Intensity Modulated Radiation Therapy   (IMRT). (Click here for an abstract of this trial).Biography
DAVID C. RICE, M.B., B.CH., B.A.O.; F.R.C.S.IAssociate   Professor, Department of Thoracic and Cardiovascular Surgery, Division   of Surgery/The University of Texas M. D. Anderson Cancer Center,   Houston, TX
Phone: (713) 794-1477Dr.   Rice's main area of clinical interest lies in the surgical management   of mesothelioma. In collaboration with colleagues in Radiation  Oncology,  he has furthered research into intensity modulated radiation  therapy  after surgical resection of mesothelioma. His research has lead  to  improved ways of preoperative staging of mesothelioma, and he has   participated in neoadjuvant trials of chemotherapy and novel targeted   agent.BiographyDAVID J. SUGARBAKER, MDChief,   Division of Thoracic Surgery/Brigham and Women's Hospital, Boston, MA   Chief, Department of Surgical Services/Dana-Farber Cancer Institute,   Boston, MA
Phone: (617) 732-6824Dr.   Sugarbaker believes in aggressive treatment of pleural mesothelioma.  He  is a proponent of tri-modal therapy; extrapleural pneumonectomy,   chemotherapy and radiation.Click here for an article by Dr. David J. Sugarbaker that appeared in the The Journal of Thoracic and Cardiovascular Surgery, January 1999 (12 pages in Adobe PDF format).BiographyLAMBROS ZELLOS, MD, MPHAttending   Thoracic Surgeon; Clinical Co-Director of the International   Mesothelioma Program/Brigham & Women's Hospital/Dana Farber Cancer   Institute Harvard Medical School, Boston, MA
Phone: (617) 525-9657Dr.   Zellos is an Attending Thoracic Surgeon and the Clinical Co-Director  of  the International Mesothelioma Program. Dr. Zellos is a proponent of   tailored multimodality therapy for each individual patient.  Appropriate  therapy may include surgery such as pleurectomy or  extrapleural  pneumonectomy with chemotherapy or radiation. Dr. Zellos  has published  several papers on multimodality therapy as well as  methods to improve  surgical techniques. VALERIE W. RUSCH, FACSAttending Thoracic Surgeon/Memorial-Sloan Kettering Cancer Center, New York, NY
Phone: (212) 639-5873Dr. Rusch is known for the treatment of pleural mesothelioma. She has published several papers comparing pleural decortication to extrapleural pneumonectomy.BiographyRAJA M. FLORES, MDChief of Thoracic Surgery Mount Sinai Medical Center, New York, NY
Phone: (212) 241-9466 (ask for Lina)Dr.   Flores is currently the Principal Investigator on a clinical trial of   neoadjuvant gemcitabine and cisplatin followed by extrapleural   pneumonectomy and high dose radiation, as well as being involved in a   trial of neoadjuvant Alimta/cisplatin, extrapleural pneumonectomy and   high dose radiation. He has also compiled a 1,000 patient database to   research areas of failure, and how to improve treatments for   mesothelioma.BiographyPress Release from Mt SinaiPAUL H. SUGARBAKER, MD, FACS, FRCSDirector, Surgical Oncology/Washington Cancer Institute, Washington, DC
Phone: (202) 877-3908Dr. Sugarbaker is a specialist in the treatment of peritoneal mesothelioma using a combination of surgery, chemotherapy and radiation.BRIAN W. LOGGIE, MDProfessor   of Surgery, Creighton University Medical School; Chief, Division of   Surgical Oncology; Director of Cancer Center/Creighton University   Medical Center, Omaha, NE
Phone: (402) 280-4100Dr.   Loggie specializes in the treatment of peritoneal mesothelioma and   peritoneal carcinomatosis. His protocol, based on eligibility, involves   surgical debulking in combination with intraperitoneal heated   chemotherapy.BiographyDAVID L. BARTLETT, MDProfessor of Surgery, Chief, Division of Surgical Oncology/UPMC Cancer Pavilion, Pittsburgh, PA
Phone: (412) 692-2852Dr.   Bartlett has particular expertise in the management of advanced,   complex abdominal malignancies. He also has a research interest in   treating advanced carcinomas in the peritoneal cavity, including   peritoneal mesothelioma.CLAIRE F. VERSCHRAEGEN, MDDirector,   Clinical Trial Office and Investigational Drug Program/Cancer Research   and Treatment Center, University of New Mexico, Albuquerque, NM
Phone: (505) 272-4551Dr.   Verschraegen is currently conducting a front-line Alimta/gemcitabine   trial for peritoneal mesothelioma patients. She also offers the   following Phase I trials for patients who have already been treated with   Alimta:Phase I Study of Capecitabine with Cisplatin and Irinotecan in Patients with Advanced MalignanciesPhase   I Study of Intravenous TZT-1027 and Gemcitabine, Administered on Day 1   and Day 8 of a Three Week Course in Patients with Advanced Solid  TumorsPhase I Study of Flavoperidol in Combination with Gemcitabine and Irinotecan in Patients with Metastatic CancerBiographyDAVID P. MASON, MDStaff Surgeon, Department of Thoracic and Cardiovascular Surgery/Cleveland Clinic Foundation, Cleveland, OH
Phone: (216) 444-4053Dr.   Mason is a proponent of aggressive multimodality therapy for malignant   mesothelioma. This includes extrapleural pneumonectomy, chemotherapy  and  radiation with Intensity Modulated Radiation Therapy (IMRT).  Cleveland  Clinic Foundation has amultidisciplinary Thoracic Oncology team with extensive experience and clinical trials in the management of malignant mesothelioma.BiographyDAVID M. JABLONS, MDAssistant Professor of Surgery Chief, General Thoracic Surgery/UCSF Mt. Zion Medical Center, San Francisco, CA
Phone: (415) 885-3882Dr. Jablons treats pleural mesothelioma with a radical pleurectomy/decortication and is researching other therapies.BiographyLARY A. ROBINSON, MDDirector,   Division of Cardiovascular and Thoracic Surgery Principal Thoracic   Surgical Oncologist/H. Lee Moffitt Cancer Center and Research Institute,   Tampa, FL
Phone: (813) 972-8412Dr. Robinson is a member of the multidisciplinary   thoracic oncology group at H. Lee Moffitt Cancer Center which  evaluates  and treats all stages of mesothelioma. He is also involved in  clinical  research programs for lung cancer and mesothelioma.BiographyCRAIG W. STEVENS, MD, PHDDivision Chief, Radiation Oncology/H. Lee Moffitt Cancer Center & Research Institute/Tampa, FL
Phone: (813) 972-8424 BiographyROBERT N. TAUB, MDProfessor   of Clinical Medicine, Columbia University College of Physicians and   Surgeons/New York Presbyterian Hospital, New York, NY
Phone: (212) 305-4076Dr.   Robert Taub is a medical oncologist who directs the Connective Tissue   Oncology Program at the Herbert Irving Comprehensive Cancer Center,   where there are a number of ongoing multimodality studies of patients   with pleural and peritoneal mesothelioma. The Center is based at the   Columbia University College of Physicians and Surgeons.Click here for a press release announcing a new multimodality study.BiographyDANIEL STERMAN, MDAssistant Professor, Department of Medicine/University of Pennsylvania Medical Center, Philadelphia, PA
Phone: (215) 614-0984Dr. Sterman is the co-author of several informative articles on treatment and clinical trials for pleural mesothelioma.BiographyERIC VALLIERES, MDAssociate Professor of Surgery, Section of General Thoracic Surgery/University of Washington Medical Center, Seattle, WA
Phone: (206) 598-4477Dr. Vallieres uses a multidisciplinary approach to thoracic malignancies and related clinical trials. Please see Medical Journal & News Articles   for an article Dr. Vallieres co-authored on Induction Chemotherapy,   Extra Pleural Pneumonectomy And Adjuvant Fast Neutron Radiationtherapy   For Pleural Mesothelioma (Dmm).BiographySTEPHEN C. YANG, MDChief,   Division of Thoracic Surgery/Associate Professor of Surgery and   Oncology/Surgical Director, Lung Transplantation Program/Director,   Thoracic Oncology Program/Johns Hopkins Medical Institutions, Baltimore,   MD
Phone: (410) 614-3891BiographyMARK J. KRASNA, MDMedical Director of the Cancer Institute at St. Joseph Medical Center/Towson, MD
Phone: (410) 427-2220Dr.   Krasna is the former Head of the Division of Thoracic Surgery,   Professor of Surgery and Associate Director for Surgical Oncology in the   Greenebaum Cancer Center at the University of Maryland Medical Center.Dr.   Krasna is a leader in the development of thoracic surgery. He is the   author of the first textbook on thoracoscopic surgery and has instructed   surgeons worldwide on his techniques.BiographyDAVID H. HARPOLE, JR., MDAssociate Professor of Surgery, Thoracic Oncology Program/Assistant
Professor of Pathology, Duke University Medical Center, Durham, NC
Phone: (919) 668-8413BiographyHARVEY PASS, MDProfessor   and Chief, Division of Thoracic Surgery and Thoracic Oncology,   Department of Cardiothoracic Surgery/NYU School of Medicine and   Comprehensive Cancer Center/New York, NY
Phone: (212) 263-7417GREGORY P. KALEMKERIAN, MDCo-Director of Thoracic Oncology/University of Michigan Comprehensive Cancer Center/Ann Arbor, MI
Phone: (734) 936-5281Dr.   Kalemkerian directs the multidisciplinary thoracic oncology clinic at   the University of Michigan Cancer Center, in addition to collaborating   with the thoracic oncology team at Karmanos Cancer Institute, to  develop  novel clinical trials for mesothelioma patients.JOSEPH S. FRIEDBERG, MDChief of Thoracic Surgery/University of Pennsylvania at Presbyterian, Philadelphia, PA
Phone: (215) 662-9195Dr. Friedberg is currently the Principal Investigator on a trial of photodynamic therapy for pleural malignancies, and also on a trial combining Alimta/cisplatin, surgery and XRT.ROBERT CAMERON, MDUCLA Medical Center, Los Angeles, CA
Phone: (310) 794-7333
Labels:
SPACIALIST

0 yorum:
Yorum Gönder